Alert : The site is undergoing maintenance. Some functionality including sign-in may be impacted
Ordering can continue through fax and phone.
Contact us
Contact us
See More
BD announced the commercial launch of a new single-cell research tool to help scientists better understand how the molecular machinery within a cell functions and how it regulates changes in a cell that can lead to cancer and other diseases.
BD announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduce human error when conducting large-scale single-cell multiomics experiments.
BD announced the worldwide commercial launch of a new automated instrument that prepares samples for clinical diagnostics using flow cytometry, enabling a complete “walkaway” workflow solution designed to improve standardization and reproducibility in cellular diagnostics.
BD announced the worldwide commercial launch of the BD FACSDiscover™ S8 Cell Sorter, a new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
The BD Rhapsody™ HT Xpress System enables scientists to isolate, barcode and analyze single cells at a high sample throughput — up to eight times more cells than prior versions of BD single-cell analyzers.
Flow cytometry is an essential tool used to analyze single cells based on their characteristics, letting scientists study them in more detail to better understand health and disease. Traditional flow cytometry workflows can be inefficient, time consuming and involve many incompatible systems.
Innovation is the engine that drives the life sciences. And since the 1970s when BD first pioneered flow cytometry—which remains one of the most powerful tools for life scientists, allowing them to study cells to better understand changes linked to disease—BD has remained at the forefront, developing increasingly sophisticated and capable technologies that enable scientists to gain deeper insights that have led to new and more effective treatments for humanity.
BD Rhapsody™ TCR/BCR Multiomic Assay speeds discovery in autoimmune disorders, immuno-oncology and infectious diseases.
BD Biosciences announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published as the cover story of the January 21st issue of the journal Science profiles a new BD innovation in flow cytometry that adds fluorescence imaging and image-based decisioning to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present.
The new BD FACSymphony™ A5 SE Cell Analyzer is a fluorescence-activated, spectral-enabled cell analyzer that offers researchers the ability to choose between spectral or compensation-based cell analysis to meet different flow cytometry needs..
The new BD FACSymphony™ A1 Cell Analyzer is a fluorescence-activated cell analyzer that offers advanced research capabilities in a compact design, which helps improve
access to instrumentation for complex scientific research to more labs.
